ClinicalTrials.gg
Status unknownNCT04404972Updated Mar 28, 2023

Incidence of Complications of Brain Death

An observational study in Brain Death, sponsored by Brno University Hospital. Status unknown at 1 site in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-28.

Sponsored by Brno University Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to describe the incidence of complications in brain death adult organ donors.

Read the detailed description

Pathophysiological changes following brain death may complicate the care of brain death donors. These complications negatively affects function of donated organs. Understanding these complications and its incidence is crucial for their appropriate management. The aim of this retrospective observational study is to evaluate the incidence of complications in adult brain death organ donors. Date will be collected from medical records of eligible patients admitted to intensive care unit for suspected brain death in whom brain death was confirmed and who become organ donors.

02

Conditions studied

  • Brain Death

Browse trials for

Keywords

  • Brain Death
  • Organ Donation
03

In context

Brain Death

74 studies on the registry are indexed under Brain Death; 10 are open to participants now.

This study's planned enrollment of 50 is below the median of 80 across 33 observational studies indexed under Brain Death.

Browse Brain Death studies →

Lead sponsor

Brno University Hospital is the lead sponsor of 91 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult critically ill patinets with confirmed brain death admitted to university hospital who become brain death organ donor.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age ≥18 years
  • confirmed brain death
  • organ donor

Exclusion criteria

Exclusion Criteria:

  • age under 18 years
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Hypotension

    Hypotension is defined as increase of vasoactive drug dose by 20% or systolic blood pressure lower than 90 mmHg or need for fluid resuscitation after initial normovolemia was achieved

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  2. Serum lactate level

    Maximal lactate level will be evaluated during ICU stay

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  3. Catecholamine storm

    Catecholamine storm is defined as onset of tachycardia and/or hypertension

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  4. Myocardial dysfunction

    Myocardial dysfunction is defined as left ventricle ejection fraction under 50% on trans-thoracic echocardiography or S-T segment depression or elevation or T wave negativity or positive troponin serum level

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  5. ARDS

    ARDS is defined and stratified according to Berlin definition

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  6. Oxygenation index

    Oxygenation index will be calculated as PaO2 divided by FiO2

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  7. Diabetes insipidus

    Diabetes insipidus is defines as urine output more than 4ml/kg per hour or urine specific gravity under 1010

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  8. Renal dysfunction

    Renal dysfunction is defined as presence of at least one of these criteria: absolute increase in serum creatinine ≥0.3 mg/dL (≥26.4 μmol/L) or increase in serum creatinine ≥1.5x above baseline or oliguria (urine output \<0.5 mL/kg per hour) for \>6 hours

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  9. Coagulopathy

    Coagulopathy is defined as international normalised ratio above 1,5 or platelet count below 100 000 per microliter

    Time frame: 48hours prior confirmation of brain death to ICU discharge

  10. Hypothermia

    Body temperature below 36°C or need for external warming

    Time frame: 48hours prior confirmation of brain death to ICU discharge

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2022 (actual). Primary completion is estimated for Dec 2023, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2020
First posted
May 28, 2020
StartActual
Apr 1, 2022
Primary completionEst.
Dec 1, 2023
CompletionEst.
Dec 1, 2023
Last update
Mar 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04404972
Lead sponsor
Brno University Hospital
Responsible party
Ondrej Hrdy (Principal Investigator, Brno University Hospital) — Principal investigator
First posted
May 28, 2020
Start date
Apr 1, 2022
Primary completion
Dec 1, 2023 (estimated)
Completion
Dec 1, 2023 (estimated)
Last update
Mar 28, 2023

Study contacts

Ondrej Hrdy, MD
Contact
hrdy.ondrej@fnbrno.cz
532233850 ext. +420
Viktor Agalarev, MD
Contact
agalarev.viktor@fnbrno.cz
532233850 ext. +420
Roman Gal, MD, PhD
study chair · University Hospital Brno

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion